Company information:
The Pharmaceutical Code Company Ltd (No: 06656906)
Address: UNIT 1, MERE VIEW BARN PARK LANE, PICKMERE, KNUTSFORD, WA16 0LG, ENGLAND
Status: Active
Incorporated: 25-Jul-2008
Accounts Next Due: 31-Dec-2024
Next Confirmation Statement Due: 08-Aug-2024
Industry Class: 70229 - Management consultancy activities other than financial management
Current Director: EWAN JAMES CAMPBELL ( DOB: Feb-1964 From: Jul-2008 )
Current Director: GIORGIO ANDREW JONES ( DOB: Mar-1961 From: Nov-2022 )
Current Director: PAOLO MORELLI ( DOB: Jun-1971 From: Nov-2022 )
Current Secretary: DARREN MARK PALMER ( From: Nov-2019 )
Resigned Director: KERRI CLARE CAMPBELL ( DOB: Apr-1971 From: Aug-2019 To: Nov-2022 )
Resigned Director: CATHERINE ELIZABETH HEAD ( DOB: Apr-1954 From: Jul-2008 To: Feb-2016 )
Resigned Director: TERESA MARY LYNCH ( DOB: Oct-1956 From: Jul-2008 To: Jun-2010 )
Resigned Director: CHRISTOPHER JOHN MAY ( DOB: Jul-1953 From: Jul-2008 To: Jun-2012 )
Resigned Director: RICHARD MOULSON ( DOB: Apr-1961 From: Nov-2019 To: Dec-2021 )
Resigned Secretary: BUSINESSLEGAL SECRETARIES LIMITED ( From: Jul-2008 To: Aug-2011 )
Persons of Significant Control:
Mrs Kerri Clare Campbell, Booths Hall, Suite M3 Chelford Road, Knutsford, WA16 8GS, England: Ownership of shares – More than 25% but not more than 50% (Notified: 2019-08-27, Ceased: 2022-11-01)
Mr Ewan James Campbell, Booths Hall, Suite M3 Chelford Road, Knutsford, WA16 8GS, England: Ownership of shares – More than 25% but not more than 50% (Notified: 2017-07-17, Ceased: 2022-11-01)
Company Accounts Summary (£)
| Item | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | Chart |
|---|---|---|---|---|---|---|---|---|---|
| Called up share capital not paid, not expressed as current asset | 0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0 | ||||||||
| Fixed assets | 56,439 | 57,125 | 60,303 | 0.0,0.0,0.0,0.0,56439.0,57125.0,60303.0,0.0 | |||||
| Current assets | 6,469 | 6,413 | 13,114 | 11,148 | 261,542 | 407,736 | 726,265 | 463,046 | 6469.0,6413.0,13114.0,11148.0,261542.0,407736.0,726265.0,463046.0 |
| Prepayments and accrued income, not expressed within current asset subtotal | 8,291 | 6,428 | 17,022 | 0.0,0.0,0.0,0.0,8291.0,6428.0,17022.0,0.0 | |||||
| Net current assets (liabilities) | 6,469 | 6,395 | 11,240 | 11,148 | 133,397 | 274,193 | 582,379 | 442,796 | 6469.0,6395.0,11240.0,11148.0,133397.0,274193.0,582379.0,442796.0 |
| Total assets less current liabilities | 6,469 | 6,395 | 11,240 | 11,148 | 189,836 | 331,318 | 642,682 | 442,796 | 6469.0,6395.0,11240.0,11148.0,189836.0,331318.0,642682.0,442796.0 |
| Provisions for liabilities, balance sheet subtotal | 403 | 1,007 | 1,007 | 0.0,0.0,0.0,0.0,0.0,403.0,1007.0,1007.0 | |||||
| Accrued liabilities, not expressed within creditors subtotal | -61,673 | -85,570 | -91,820 | 0.0,0.0,0.0,0.0,-61673.0,-85570.0,-91820.0,0.0 | |||||
| Net assets (liabilities) | 6,469 | 6,395 | 11,240 | 11,148 | 128,163 | 245,345 | 549,855 | 441,789 | 6469.0,6395.0,11240.0,11148.0,128163.0,245345.0,549855.0,441789.0 |
| Equity / share capital and reserves | 6,469 | 6,395 | 11,240 | 11,148 | 128,163 | 245,345 | 549,855 | 441,789 | 6469.0,6395.0,11240.0,11148.0,128163.0,245345.0,549855.0,441789.0 |